Funding was led by New Enterprise Associates, with participation from Foresite Capital and multiple other investors.

Sanofi-backed Abcuro has secured $200 million in series C funds to power its anti-KLRG1 antibody through a phase 2/3 muscle ...

Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced the ...

Barasia brings over 30 years of experience in consulting, strategy development and business operations to Bay Capital's ...

Bain Capital LP is raising a S$460 million ($340 million) loan to back its purchase of Blackstone Inc.’s Singapore-based ...

Index was cofounded in late 2023 by Simon Kubica, who spent five years at Atlassian and Christian Iacullo, who spent similar ...

Corporate Venture Capital (CVC) investment is an increasingly used strategic tool that enables large corporations to make ...

The Australia-based startup gets seed funding to enhance product management tools, facilitating idea tracking and roadmap ...

Onebrief is pushing to further develop its software for military staff in their planning and other operational activities.

Chemical companies in the US and Europe began exiting the pharmaceutical industry in the mid-1990s, when the British firm ICI ...

Global markets are in a wait-and-see mode as President Trump vows to slap steel and aluminum tariffs, among other levies, on ...

Global private equity and venture capital transaction value totaled $35.28 billion in January, down slightly compared with ...